Latham & Watkins LLP has advised Remix Therapeutics. Fenwick & West LLP has advised Passage Bio. Cooley LLP has advised Goldman Sachs & Co. LLC, Jefferies...
Remix Therapeutics and Passage Bio Announce Merger and $100 Million Private Placement
BitGo Raises $212 Million in Initial Public Offering on NYSE
Fenwick & West has advised BitGo. BitGo, a digital asset infrastructure company, has completed its initial public offering, raising approximately $212 million. The offering consisted of...
CoreWeave’s $2 Billion Upsized IPO
Fenwick & West represented CoreWeave, Inc. in the offering, and Latham & Watkins represented the underwriters. CoreWeave, Inc. (Nasdaq: CRWV), a developer of a cloud infrastructure...
ACELYRIN’s Merger with Alumis
Fenwick & West and Paul Hastings advised ACELYRIN, INC. on the transaction, and Cooley advised Alumis Inc. ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company...




























